Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-02-04 @ 9:51 AM
Study NCT ID:
NCT05317767
Status:
COMPLETED
Last Update Posted:
2022-04-08
First Post:
2021-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.
Sponsor:
St. Petersburg Research Institute of Vaccines and Sera
Organization: